Medicine and Dentistry
Cytoreductive Surgery
100%
Hyperthermic Intraperitoneal Chemotherapy
95%
Peritoneum Metastasis
80%
Breast Cancer
38%
Sentinel Lymph Node
37%
Overall Survival
35%
Systemic Therapy
34%
Peritoneum Mesothelioma
32%
Colorectal Carcinoma
31%
Neoplasm
26%
Metastatic Carcinoma
21%
Sentinel Lymph Node Biopsy
20%
Cohort Analysis
20%
Rectum Cancer
19%
Recurrent Disease
16%
Peritoneum Cancer
15%
Breast Carcinoma
14%
Pleura Mesothelioma
13%
Cross Sectional Study
13%
Mesothelioma
13%
Retroperitoneal Lymph Node Dissection
12%
Axillary Lymph Node
12%
Peritoneum
12%
Adverse Event
12%
Irinotecan
11%
Arm
10%
Intraperitoneal Chemotherapy
10%
Progression Free Survival
10%
Sentinel Node
8%
Lymph Node
8%
Skeletal Muscle
8%
Bevacizumab
8%
Percutaneous Coronary Intervention
8%
Hazard Ratio
8%
Computer Assisted Tomography
8%
Disease Free Survival
8%
Cancer
8%
FOLFOX
7%
Patient-Reported Outcome
7%
Cancer Therapy
7%
Postoperative Complication
7%
Retrospective Study
7%
Clinical Trial
7%
Randomized Controlled Trial
7%
Paclitaxel
7%
Diseases
7%
Internal Mammary Lymph Node
7%
Radioactive Tracer
7%
Micrometastasis
6%
Chemoradiotherapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Intraperitoneal Chemotherapy
51%
Peritoneum Metastasis
46%
Peritoneal Mesothelioma
26%
Colorectal Carcinoma
22%
Overall Survival
20%
Chemotherapy
19%
Neoplasm
17%
Peritoneum Cancer
15%
Bevacizumab
14%
Cohort Study
14%
Mesothelioma
13%
Pleura Mesothelioma
13%
Adverse Event
12%
Irinotecan
10%
Oxaliplatin
9%
Pharmacokinetics
9%
Recurrent Disease
8%
Progression Free Survival
7%
Fluorouracil
7%
Malignant Neoplasm
6%
Breast Cancer
6%
Cross-Sectional Study
6%
C Reactive Protein
6%
Micrometastasis
6%
Breast Carcinoma
6%
Phase II Trials
6%